Introduction
Acute Respiratory Distress Syndrome (ARDS) is characterized by inflammation-mediated alveolar/capillary barrier dysfunction with interstitial and airspace protein-rich edema fluid, resulting in ventilation-perfusion mismatch and consequent severe hypoxemia [
1]. Several ventilatory strategies are implemented in these patients to restore adequate oxygenation; however, mechanical ventilation itself can increase damage to the lung tissue [
2]. The inflammatory changes, the loss of airspace capacity secondary to lung collapse and the dynamic reopening of distal lung units during mechanical ventilation, result in a marked decrease in lung compliance. Furthermore, an increase in lung resistance has also been reported, which was partially attributed to impaired peripheral airway function [
3]. Studies that report expiratory flow limitation and dynamic hyperinflation in patients with ARDS also indicate that these functional alterations are related to airway closure [
4‐
7]. Recent studies suggest a role for distal airway epithelium injury in the pathophysiology of human acute lung injury (ALI) and propose that Clara cell CC16 protein levels in plasma and pulmonary edema fluid can be used as a biomarker for the diagnosis of ALI/ARDS [
8].
Several experimental models have been proposed to reproduce the functional and morphological lung changes in ARDS. Models of ventilation-induced lung injury have shown that ventilation of normal or lavaged lungs with low end-expiratory lung volume causes a persistent increase in airway resistance and histological evidence of peripheral airway injury characterized by bronchiolar epithelial necrosis and sloughing and rupture of alveolar-bronchiolar attachments [
9‐
13]. These morphological and functional alterations have been mainly attributed to shear stresses caused by cyclic opening and closing of peripheral airways [
3,
7].
Since airway mechanics is largely dependent on airway structure, extracellular matrix (ECM) composition and distribution, in addition to airway-parenchyma interdependence forces, the functional airway alterations observed in ARDS patients are likely associated with airway morphological changes [
14]. Although both human and experimental studies have suggested that airway changes contribute to impaired lung function in acute lung injury, no study to date has focused on distal airway morphological changes in the lungs of human subjects with ARDS. Therefore, the aim of the present study was to analyze the structural and inflammatory changes in small airways of patients with ARDS. For this purpose, we measured the extent of epithelial alterations, airway dimensions and the expression of major lung ECM elements and their regulators within the small airway walls of patients with ARDS submitted to autopsy and compared them with control subjects. We further correlated the airway changes to clinical data and mechanical ventilation parameters.
Discussion
In the present study, we analyzed for the first time the structural changes in small airways in patients with ARDS compared to control subjects. Our main findings were the presence of epithelial denudation, airway inflammation and increased thickness of small airway walls with deposition of collagen I, fibronectin and versican, mainly localized to the outer wall.
Recent studies have suggested that the peripheral airways play an important role in the pathophysiology of ALI/ARDS [
3]; however, no study has focused on airway morphological changes in lungs from human subjects with ARDS. Experimental models of ALI are used to investigate these changes and have shown epithelial necrosis and denudation in distal airways of animals ventilated with low lung volumes [
9‐
12]. Our results are in line with these experimental studies and show that bronchiolar epithelium denudation is also present in humans and is associated with ARDS severity. The mechanisms of epithelial injury and denudation are not completely understood but are likely to result from changes in shear stress due to reopening of either collapsed small airways or non-collapsed flooded airways [
7,
22] and from stretch-induced hyperdistension of epithelial cells [
23]. Gadigliali and Gaver (2008) suggested that this increased stress on the airway epithelial cell lining may induce significant cellular deformations, cell death, and/or disruption of cell adhesions. The damaged epithelial cell may in turn upregulate inflammatory pathways and/or alter surfactant secretion [
24].
Airway inflammation is diffusely present in surfactant-depleted lungs of rabbits submitted to low end-expiratory lung volume ventilation [
13] and in rats submitted to high volume-induced lung injury [
23]. Our results show that distal airway inflammation is also present in human ARDS lungs. Whether airway inflammation in ARDS represents a response of terminal bronchioles to the primary insult or is rather a spreading of inflammatory cells from the alveolar tissue is not clear. In either case we suggest that airway inflammation is likely to be involved in the pathogenesis of airway remodeling in ARDS.
Previous studies evaluating ECM changes in ARDS have shown altered alveolar septa with lung fibrosis [
25] and increased alveolar content of collagen and elastic fibers [
26‐
28], fibronectin [
29] and versican [
30] in exudative and/or proliferative phases of lung injury. The fibroproliferative process characterized by collagen deposition, even in the early phase of ARDS, is associated with a severe reduction in respiratory system compliance [
31]. We show for the first time that remodeling is also present at the terminal bronchiolar level and suggest that these structural airway changes may also have functional implications. The functional consequences of airway remodeling are dependent on which layer in the airway wall is changed as well as on the composition and mechanical properties of the material that is altered [
32]. The inner area provides resistance of the tissue to compression; the smooth muscle layer is usually altered in pulmonary diseases characterized by bronchoconstriction; and the outer wall is directly attached to the lung parenchyma and is, therefore, crucial for the maintenance of lung tissue structure and transmission of elastic forces. Thus, we believe that airway compartmentalization provides important insight toward a better understanding of structure-function relationships in pulmonary diseases. Airway dysfunction in patients with ARDS who are ventilated with low PEEP is characterized by expiratory flow limitation and gas trapping [
4,
5], which have been related to airway closure and inhomogeneous distribution of ventilation [
6,
7]. The mechanisms involved in airway closure include surfactant dysfunction and a decrease in airway-parenchyma interdependence secondary to interstitial edema, alveolar collapse, and possibly the rupture of alveolar attachments [
3,
11,
12]. Since the outer airway layer is the main region where mechanical forces are transmitted from the alveolar parenchyma to the airway wall, it represents a critical site that may be affected by both the inflammatory process and the mechanical damage caused by abnormal stress. Interestingly, in this study collagen I, fibronectin and versican levels were primarily increased in the outer airway wall, which could contribute to airway-parenchyma uncoupling by altering the mechanical interdependence between these two compartments.
The higher MMP-9 expression seen in the ARDS group is in accordance with previous studies showing increased levels of MMP-9 in the bronchoalveolar lavage of patients with ARDS [
33,
34]. The observation of increased MMP-9 expression in inflammatory cells within the airway wall suggests that MMP-9 may be involved in airway ECM remodeling in ARDS patients. Increased MMP-9 expression could either be associated with higher ECM turnover within the airway wall or represent a response to excessive matrix deposition in an attempt to restore equilibrium to the ECM composition.
In chronic airway inflammatory lung diseases, airway remodeling is correlated with marked changes in airway mechanics and symptoms related to airway obstruction [
14]. Although airway obstruction is not a characteristic of ALI, patients who survive ARDS can present mild to moderate abnormalities in lung function evidenced by decreased FEV
1, FVC and/or FEV
1/FVC evaluated one to three years after hospital discharge [
35‐
37]. It is possible that the persistence of these pulmonary function changes is related to airway remodeling.
To determine if the airway changes were different in patients with distinct predisposing factors, ARDS patients were divided into pulmonary and extrapulmonary subgroups. Although we observed higher levels of MMP-9 in the airways from the ARDSp subgroup, there were no differences in the inflammation index or in any structural parameter between the ARDSp and ARDSext subgroups. These findings suggest that the airway alterations in ARDS were the result of the inflammatory insult (and/or ventilator injury), independent of the primary cause. We also categorized our ARDS patients into two subgroups according to time interval between ARDS diagnosis and death. We did not find any significant differences in inflammatory or structural parameters between patients who died in the first week and patients who died more than seven days after diagnosis, suggesting that the airway alterations were present at the start of the syndrome and were maintained over time.
Pulmonary injury is heterogeneously distributed in ARDS, resulting in inhomogeneous ventilation and predisposing the lung to ventilator-induced lung injury [
2]. Previous studies suggest that lung injury in ALI is more severe in the atelectatic dependent lung regions [
38,
39]; however, more recent studies have suggested that the peripheral airway injury observed in experimental ALI is diffusely distributed in both dependent and non-dependent regions [
13]. One limitation of our study was the retrospective analysis of lung tissue, which did not allow us to systematically assess regional differences in airway injury in these lungs from human subjects with ARDS. Due to the retrospective character of the study, another limitation was the lack of systematic recording of clinical data. In many charts, information regarding smoking habits or the specifics of the lung mechanics was not available, which could have influenced the interpretation of our results. Furthermore, since we only analyzed tissue from patients who died, the extent to which the results obtained in the present study can be transposed to the less severe cases of ARDS is unclear.
Although the observed airway changes are likely to play a role in the pathogenic mechanisms of ALI, it is not clear if these changes are due to the insult leading to ARDS or to ventilator injury. It is well known that pulmonary injury in ARDS patients can be exacerbated by the ventilatory strategy [
2], as indicated by clinical trials showing significantly higher mortality among patients who received ventilation with high tidal volume and high inspiratory plateau pressures [
40‐
42]. In our patients, airway epithelial injury showed significant correlations with PaO
2/FiO
2 and inspiratory pressure values, suggesting that both the primary pulmonary insult leading to ARDS and the ventilator injury are associated with airway structural alterations in ARDS patients. Rouby
et al.
[
43] analyzed the histological aspects of pulmonary barotrauma in critically ill patients with acute respiratory failure and observed in 6 out of 30 lungs severe damage to terminal bronchioles characterized by bronchiolar dilation, epithelial hyperplasia and metaplasia. Similarly to our results, the authors suggested that mechanical ventilation with a high peak airway pressure plays a role in the pathogenesis of bronchial injury and airspace enlargement.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
MMBM participated in the design of the study, carried out the immunohistochemistry reactions and the morphometric analyses, performed the statistical analysis and drafted the manuscript. RCPN and NI helped to carry out the morphometric analyses and were involved in drafting the manuscript. TL helped to carry out the morphometric analyses, was involved in the acquisition of clinical data and was involved in revising the manuscript. LFFS participated in the design of the study, performed the histological analysis and the immunohistochemistry quality control, helped at the statistical analysis and was involved in drafting the manuscript. PHNS and TM contributed to the conception and design of the study and were involved in drafting the manuscript. CRRC and MBPA contributed to the conception and design of the study, contributed to analysis and interpretation of data and were involved in revising the manuscript. MD conceived the study, performed the histological analysis, performed the immunohistochemistry quality control, performed the statistical analysis, drafted and revised the manuscript. All authors read and approved the final version of the manuscript.